Table 1.

Patient Demographics and Clinical Characteristics

Characteristic	Erlotinib		Erlotinib Plus Carboplatin and Paclitaxel		All Patients
	No.	%	No.	%	No.	%
No. of patients	81		100		181
Age, years
Median	58		60		59
Range	32-78		34-81		32-81
Sex
Male	32	40	42	42	74	41
Female	49	60	58	58	107	59
Ethnicity
White	61	75	84	84	145	80
African American	12	15	6	6	18	10
Asian	5	6	8	8	13	7
Other	2	3	1	1	3	2
Unknown	1	1	1	1	2	1
ECOG performance status
0	50	62	48	48	98	54
1	31	38	52	52	83	46
Smoking history
Never smoker	64	79	79	79	143	79
Light former smoker	17	21	21	21	38	21
Histology
Adenocarcinoma	71	88	84	84	155	86
Bronhioloalveolar cancer	2	2	2	2	4	2
Adenocarcinoma with bronchioloalveolar features	8	10	14	14	22	12

Abbreviation: ECOG, Eastern Cooperative Oncology Group.